Alpa Laboratories Management Change
Alpa Laboratories Ltd has appointed Ms. Diksha Jaswani as the Company Secretary and Compliance Officer (KMP), effective September 17, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Alpa Laboratories Ltd has appointed Ms. Diksha Jaswani as the Company Secretary and Compliance Officer (KMP), effective September 17, 2026.
Alpa Laboratories Ltd. has submitted its Annual Report for FY 2025-26 and the Notice for its 38th Annual General Meeting scheduled for September 30, 2026.
Alpa Laboratories will close its transfer register from 23 to 30 Sept 2026 for the 38th AGM. This is a routine book-closure intimation under Regulation 42 with no financial impact.
Alpa Laboratories appointed Mrs. Radhika Biyani as an Additional Independent Director, effective 5 September 2026. Board committees were reconstituted following the change.
Alpa Laboratories Ltd reported revenue from operations of ₹23.9 Cr (+25.1% YoY) and net profit of ₹1 Cr (-91.5% YoY) for Q1 FY27.
Alpa Laboratories Ltd. will hold a board meeting on August 13, 2026, to consider financial results for the quarter ended June 30, 2026, and approve the 38th AGM notice.
Alpa Laboratories Ltd. has approved exploring the incorporation of an overseas entity in Nigeria, 'Alpa Biopharm Limited,' in partnership with Blueseal Pharmaceuticals Limited. This is in-principle only.
Alpa Laboratories Limited clarified discrepancies in its revised consolidated financial results submitted in XBRL format. The update ensures Profit Before Tax figures align with previously signed statements.
Alpa Laboratories Limited announced the cessation of Ms. Jyoti Jain as a Non-Executive Independent Director upon the completion of her tenure, effective July 21, 2026.
Alpa Laboratories reports resignation of Company Secretary Yashoda Patidar, effective July 26, 2026. No further disclosures are required per the filing.